en · de · es · fr · pt
cardarine-notes.peptides3626.com › Guide › Background And Research Context — 2026 Update

Background And Research Context — 2026 Update

By Editorial Desk · published 2025-12-23 · last reviewed 2026-01-26 · Guide

GW501516 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-01-26. Anything still debated is marked as such rather than presented as settled.

Background and Research Context

PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.

In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.

Mechanism and Detection Methods

GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.

Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.

Cardarine at a glance

PropertyValueNotes
CAS Registry Number317318-70-0Unique identifier for the compound.
Chemical classPPARδ agonistSynthetic ligand for peroxisome proliferator-activated receptor delta.
AppearanceWhite to off-white solidTypical form of research-grade material.
SolubilitySoluble in DMSO and ethanolPoorly soluble in water.
Typical storage-20°CRecommended for long-term storage of stock solutions.

Mechanism and Detection

GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.

Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.

Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.

Related pages on this site

Mechanism and Laboratory Detection

GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.

Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Reference notes

== Additional features == In addition to the twelve sections of HPA, exploring gene and protein expression, there are various features available at the HPA website to assist the research community, including integrated external resources, such as Metabolic Atlas, educational material and free downloadable data.

Magistrate Judge Sarah Netburn by questioning her about the sexual harassment that resulted from her decision to allow an inmate who claimed to be transgender to transfer to a women's prison. Kennedy's derailment of Netburn's nomination was the first time the Democratic-led Senate Judiciary Committee rejected one of President Biden's nominees. Kennedy introduced a bill to extend the statute of limitations for victims of sexual harassment who worked for the FDIC after an independent investigation found that the agency had a culture where harassment was commonplace. As a member of the Senate Appropriations Committee, Kennedy has secured millions in federal funding for Louisiana, including several million-dollar FEMA grants to fund hurricane recovery efforts after Hurricane Laura in 2020. In the 2024 appropriations package, Kennedy also secured millions to improve the Boggs Lock and Dam on the J. Bennett Johnston Waterway. On September 17, 2024, in a hearing on rising racially motivated hate crimes in the United States, Kennedy claimed that pro-Palestinian figures promoted antisemitism. He asked Maya Berry, the incumbent executive director of the Arab American Institute, about her stance on Hamas, Hezbollah, and the Iranian regime. He also asked Berry whether she still supported the UNWRA amid claims that the organization "participated" in the October 7 massacres. Berry said: "I think it's exceptionally disappointing you're looking at an Arab American witness before you and saying you support Hamas.

The Selous Scouts was a special forces unit of the Rhodesian Army that operated during the Rhodesian Bush War from 1973 until the reconstitution of the country as Zimbabwe in 1980. It was mainly responsible for infiltrating the black majority population of Rhodesia and collecting intelligence on insurgents so that they could be attacked by regular elements of the security forces. The unit did this by forming small teams that posed as insurgents and usually included captured insurgents. Over time, the Selous Scouts increasingly attacked insurgents themselves and operated in the countries that neighboured Rhodesia. The unit developed a reputation for brutality and was responsible for attacking and killing civilians. The Selous Scouts were also involved in the Rhodesian chemical and biological weapons programme and used poisons and biological agents in some of its operations. The methods used by the unit led to the deaths of large numbers of insurgents, but proved counter-productive as they further alienated the black majority population from the white minority Rhodesian government and increased international opposition to the regime. Following the disbandment of the Selous Scouts after Rhodesia's transition to Zimbabwe, many of its members were recruited into the Apartheid-era South African security forces. They contributed to the adoption of the Selous Scouts' methods by the South African Defence Force and South African Police, and some took part in operations to undermine the government of Zimbabwe.

Sources: en.wikipedia.org

Notes from published material

Static secondary-ion mass spectrometry, or static SIMS, is a secondary-ion mass spectrometry technique for chemical analysis including elemental composition and chemical structure of the uppermost atomic or molecular layer of a solid, which may be a metal, semiconductor, or plastic, with insignificant disturbance to its composition and structure. It is one of the two principal modes of operation of SIMS, which is the mass spectrometry of ionized particles emitted by a solid (or sometimes liquid) surface upon bombardment by energetic primary particles.

==== Songs ==== "Chains" (Cookies song), 1962, covered by The Beatles "The Chain", a 1977 song by Fleetwood Mac "Chains", a song by Chicago from the 1982 album Chicago 16 "Chains" (Patty Loveless song), 1990 "Chain", a song by His Boy Elroy on their 1993 self-titled album. "Chains" (Tina Arena song), 1994 "Chains" (DLT song), 1996 "Chain", a song by the Fire Theft from their 2003 self-titled album "Chains" (Nick Jonas song), 2014 "Chains" (Usher song), 2015

India accounts for the bulk of the Indian subcontinent, lying atop the Indian tectonic plate, a part of the Indo-Australian Plate. India's defining geologic processes began approximately 70 million years ago, when the Indian Plate, then part of the southern supercontinent Gondwana, began a north-eastward drift caused by seafloor spreading to its south-west, and later, south and south-east. Simultaneously, the vast Tethyan oceanic crust, to its northeast, began to subduct under the Eurasian Plate. The Indian continental crust was obstructed and was sheared horizontally; while its lower crust and mantle slid beneath Eurasia, the upper layer piled up in sheets ahead of the subduction zone. This mountain-building orogeny created the Himalayas. The middle and stiffer layer continued to push into Tibet, causing crustal thickening of the Tibetan Plateau. Immediately south of the emerging Himalayas, plate movement created a vast crescent-shaped trough that rapidly filled with river-borne sediment and now constitutes the Indo-Gangetic Plain. The original Indian plate makes its first appearance above the sediment in the ancient Aravalli range, which extends from the Delhi Ridge in a southwesterly direction. To the west lies the Thar Desert, whose eastern spread is checked by the Aravallis.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.

Is cardarine a steroid?

No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.

What did animal studies find?

Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.

What receptor does cardarine target?

Cardarine targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not bind the androgen receptor in the way SARMs do.

Network